Improving Life by Improving Healthcare.
CVR Medical Corp. is a med-tech organization dedicated to the development and advancement of revolutionary technology at work within the healthcare sector. Specifically, The Carotid Stenotic Scan (CSS), a groundbreaking tool which will be used to assess Carotid Arterial health in a way which is unavailable to the patient, healthcare provider, and the payor within the current system. By leveraging intellectual property, market and industry know-how, and key strategic relationships, CVR Medical has entered into a trajectory which will revolutionize healthcare and dramatically improve clinical outcomes.
The Carotid Stenotic Scan (CSS) is a diagnostic tool designed to detect and determine a level of carotid narrowing for the purpose of identifying patients at risk for Ischemic Stroke.
CVR Medical Corp. is perfectly positioned to take advantage of a lucrative growing market.
Get the hard data on the global need within the medical field to screen for Carotid Artery Disease (CAD).
Annual General and Special Meeting of the Shareholders 2020
This website may contain forward looking statements, and forward looking information under applicable securities laws including management’s expectations of future production, cash flow and earnings. These statements are based on various assumptions some of which may or may not prove to be correct, and many of which are beyond the control of CVR Medical Inc. (“CVR”) and that involve a number of risks and uncertainties, which could cause actual results to differ from those anticipated. These risks and uncertainties include, but are not limited to the risks associated with the medical device industry (e.g. operational risks in development, approvals, production, delays or changes in plans with respect to development projects or capital expenditures, the uncertainty of market estimates, the uncertainty of estimates and projections relating to production, costs and expenses, health and safety risks), price and exchange rate fluctuation and uncertainties resulting from potential delays or changes in plans with respect to development, approvals, projects or capital expenditures. There can be no assurance that the forward looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. CVR undertakes no duty to update any of the forward looking information herein. The reader is cautioned not to place undue reliance on forward-looking statements. Further, there are substantial risks associated with the Company’s ability to achieve its prospects, including, without limitation, changes in applicable laws, rules, and regulations, risks associated with the economic environment, the financing markets, and risks associated with the Company’s ability to execute on its business plan. The information contained in this website has not been reviewed or approved by the U.S. Securities and Exchange Commission or any provincial or state securities regulatory authority and neither the TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this presentation. Any representation to the contrary is unlawful. The information contained in this website is only intended to provide a basic understanding of CVR in order to assist in deciding if they want to proceed with any further investigations and does not purport to be all-inclusive or to contain all information that a prospective investor may desire or that may be required in order to evaluate the business, products, prospects or value of CVR. Upon restructuring CVR Global Inc. is managing numerous supplier, sub-supplier, and consultants on behalf go CVR Medical. This presentation does not constitute an offer or solicitation to buy or sell securities. Any offer of securities of CVR will be made only pursuant to a subscription agreement and the provisions of applicable law including US Securities Laws. No securities to be offered for sale by CVR are expected to be registered in the United States under the Securities Act of 1933 as Amended or under any state securities laws. All Citations available upon request. All claims associated with regulatory and U.S. Food & Drug Administration (“FDA”) clearance are based on current information and estimations and are made on the understanding that current interpretations and opinions of the FDA may change.